Alyeska Investment Group

Alyeska Investment Group’s Revance Therapeutics, Inc. RVNC Stock Holding History

Alyeska Investment Group’s Portfolio RVNC Stock Details RVNC Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell
2022 Q3	$2.5M	Buy
2020 Q1	–	Sell
2019 Q4	$6.46M	Buy
2014 Q4	–	Sell
2014 Q3	$626K	Sell
2014 Q2	$2.04M	Buy